The triggering receptor expressed on myeloid cells 2 (TREM2), a transmembrane receptor abundantly expressed on microglia, has been identified as one of the risk factors for AD (Hashioka et al., 2020). This evidence concerns the gene TREM2 and Alzheimer disease.